FTRE

Fortrea Holdings Inc. NASDAQ

Healthcare ·Biotechnology ·US · fortrea.com

$12.25

Mkt Cap $1.1B

52w Low $3.97 56.3% of range 52w High $18.67

50d MA $9.93 200d MA $11.16

P/E (TTM) -1.1x

EV/EBITDA -1.8x

P/B 2.0x

Debt/Equity 0.1x

ROE -175.0%

P/FCF 17.8x

RSI (14) —

ATR (14) —

Beta 1.77

50d MA $9.93

200d MA $11.16

Avg Volume 1.6M

About

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 26, 2026	BMO	0.16	0.09	-43.8%	10.80	-3.4%	-0.7%	-0.7%	-2.2%	-3.0%	-3.9%	—
Nov 5, 2025	BMO	0.16	0.12	-25.0%	11.95	-0.9%	-7.8%	-7.8%	-5.9%	-6.4%	-1.3%	—
Aug 6, 2025	BMO	0.06	0.19	+216.7%	6.58	+4.6%	+10.0%	+10.0%	+0.0%	-2.9%	+11.1%	—
May 12, 2025	BMO	-0.07	0.02	+128.6%	5.19	+1.3%	-3.7%	-3.7%	-7.9%	-8.5%	-14.5%	—
Mar 3, 2025	BMO	0.36	0.18	-50.0%	10.38	-0.8%	+5.6%	+5.6%	+4.9%	+3.0%	+2.9%	—
Nov 8, 2024	BMO	0.27	0.23	-14.8%	23.50	+4.2%	-3.2%	-3.2%	-6.6%	-9.4%	-14.0%	—
Aug 12, 2024	BMO	0.07	-0.03	-142.9%	20.04	+0.5%	+10.9%	+10.9%	+15.8%	+11.9%	+11.2%	—
May 13, 2024	BMO	-0.01	-0.04	-618.7%	28.11	+0.4%	+2.6%	+2.6%	+2.3%	-1.1%	-2.0%	—
Mar 11, 2024	BMO	0.23	0.19	-17.4%	36.41	+0.1%	+4.4%	+4.4%	+6.9%	+7.5%	+7.9%	—
Nov 13, 2023	BMO	0.18	0.24	+33.3%	30.92	+3.4%	+5.0%	+5.0%	+5.7%	+4.9%	+3.1%	—
Aug 14, 2023	BMO	0.39	0.52	+33.3%	26.90	-1.4%	+1.0%	+1.0%	+0.7%	-1.4%	-3.0%	—
Mar 31, 2023	BMO	—	-0.13	—	—	—	—	—	—	—	—	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 14	Barclays	Maintains	Equal Weight → Equal Weight	—	$9.38	$9.47	+1.0%	+2.2%	+7.1%	+7.6%	+10.7%	+11.3%
Apr 8	Evercore ISI	Maintains	Outperform → Outperform	—	$9.51	$10.02	+5.4%	+1.3%	-1.4%	-3.5%	-1.4%	+0.8%
Mar 9	TD Cowen	Upgrade	Hold → Buy	—	$9.61	$9.90	+3.0%	+2.3%	-6.9%	-2.0%	-5.9%	-7.1%
Feb 27	Baird	Maintains	Outperform → Outperform	—	$10.80	$10.43	-3.4%	-0.7%	-2.2%	-3.0%	-3.9%	-8.1%
Feb 27	Barclays	Maintains	Equal Weight → Equal Weight	—	$10.80	$10.43	-3.4%	-0.7%	-2.2%	-3.0%	-3.9%	-8.1%
Jan 22	TD Cowen	Maintains	Hold → Hold	—	$17.01	$17.16	+0.9%	+2.0%	-1.1%	+0.3%	+0.6%	-1.6%
Jan 8	Truist	Upgrade	Hold → Buy	—	$17.49	$18.25	+4.3%	-0.3%	-0.6%	+5.2%	-0.7%	-4.1%
Jan 6	Evercore ISI	Upgrade	In Line → Outperform	—	$16.62	$18.12	+9.0%	+5.5%	+5.2%	+4.9%	+4.6%	+10.7%
Dec 18	Mizuho	Maintains	Neutral → Neutral	—	$16.19	$16.43	+1.5%	+2.6%	+9.6%	+9.3%	+10.6%	+9.3%
Dec 15	Barclays	Upgrade	Underweight → Equal Weight	—	$15.72	$16.34	+3.9%	+2.2%	+1.7%	+3.0%	+5.7%	+12.8%
Dec 11	Citigroup	Upgrade	Neutral → Buy	—	$15.14	$16.11	+6.4%	+2.7%	+3.8%	+6.1%	+5.6%	+6.9%
Nov 6	Barclays	Maintains	Underweight → Underweight	—	$11.95	$11.84	-0.9%	-7.8%	-5.9%	-6.4%	-1.3%	-5.1%
Oct 17	Mizuho	Maintains	Neutral → Neutral	—	$9.52	$9.29	-2.4%	-0.7%	+9.5%	+9.1%	+10.5%	+13.4%
Oct 8	Evercore ISI	Maintains	In Line → In Line	—	$9.31	$9.79	+5.2%	+8.8%	+15.5%	+4.0%	+5.5%	+2.6%
Oct 2	Barclays	Maintains	Underweight → Underweight	—	$9.52	$9.61	+0.9%	+0.8%	-0.7%	+0.7%	-2.2%	+6.4%
Sep 9	Jefferies	Maintains	Hold → Hold	—	$10.32	$10.22	-1.0%	-2.4%	-3.0%	-0.9%	-2.1%	-1.2%
Sep 3	Baird	Maintains	Outperform → Outperform	—	$10.01	$10.48	+4.7%	+6.8%	+5.0%	+16.2%	+3.1%	+0.6%
Aug 8	Evercore ISI	Maintains	In Line → In Line	—	$7.24	$7.20	-0.6%	-9.1%	-11.7%	+1.0%	+8.3%	+9.1%
Aug 7	Barclays	Maintains	Underweight → Underweight	—	$6.58	$6.88	+4.6%	+10.0%	+0.0%	-2.9%	+11.1%	+19.1%
Aug 4	Baird	Upgrade	Neutral → Outperform	—	$5.46	$6.19	+13.4%	+17.6%	+20.1%	+20.5%	+32.6%	+20.5%
Jul 11	Mizuho	Maintains	Neutral → Neutral	—	$5.27	$5.15	-2.3%	-3.0%	-4.9%	-10.4%	-7.0%	-6.1%
Jul 9	Evercore ISI	Maintains	In Line → In Line	—	$4.79	$4.87	+1.7%	+5.2%	+10.0%	+6.7%	+4.6%	-1.5%
May 14	Mizuho	Maintains	Neutral → Neutral	—	$5.00	$4.90	-2.0%	-4.4%	-5.0%	-11.2%	-11.0%	-6.2%
May 14	Goldman Sachs	Maintains	Neutral → Neutral	—	$5.00	$4.90	-2.0%	-4.4%	-5.0%	-11.2%	-11.0%	-6.2%
May 13	Barclays	Maintains	Underweight → Underweight	—	$5.19	$5.26	+1.3%	-3.7%	-7.9%	-8.5%	-14.5%	-14.3%
Apr 10	Barclays	Downgrade	Equal Weight → Underweight	—	$6.45	$6.05	-6.2%	-19.2%	-19.7%	-16.9%	-24.7%	-22.2%
Apr 9	Mizuho	Maintains	Neutral → Neutral	—	$5.70	$5.64	-1.1%	+13.2%	-8.6%	-9.1%	-6.0%	-14.7%
Mar 4	Goldman Sachs	Maintains	Neutral → Neutral	—	$10.38	$10.30	-0.8%	+5.6%	+4.9%	+3.0%	+2.9%	-1.4%
Mar 4	Evercore ISI	Maintains	In Line → In Line	—	$10.38	$10.30	-0.8%	+5.6%	+4.9%	+3.0%	+2.9%	-1.4%
Mar 4	William Blair	Maintains	Market Perform → Market Perform	—	$10.38	$10.30	-0.8%	+5.6%	+4.9%	+3.0%	+2.9%	-1.4%
Mar 4	Barclays	Maintains	Equal Weight → Equal Weight	—	$10.38	$10.30	-0.8%	+5.6%	+4.9%	+3.0%	+2.9%	-1.4%
Dec 11	Citigroup	Downgrade	Buy → Neutral	—	$21.15	$20.08	-5.1%	-8.0%	-4.2%	-5.4%	-4.0%	-6.4%
Dec 6	Baird	Downgrade	Outperform → Neutral	—	$23.57	$22.94	-2.7%	-8.1%	-4.4%	-10.3%	-17.5%	-14.0%
Nov 25	Baird	Maintains	Outperform → Outperform	—	$19.73	$20.20	+2.4%	+5.9%	+4.9%	+9.2%	+6.7%	+10.2%
Nov 11	Barclays	Maintains	Equal Weight → Equal Weight	—	$23.50	$24.48	+4.2%	-3.2%	-6.6%	-9.4%	-14.0%	-17.7%
Nov 11	TD Cowen	Maintains	Hold → Hold	—	$23.50	$24.48	+4.2%	-3.2%	-6.6%	-9.4%	-14.0%	-17.7%
Nov 11	Baird	Maintains	Outperform → Outperform	—	$23.50	$24.48	+4.2%	-3.2%	-6.6%	-9.4%	-14.0%	-17.7%
Oct 15	Barclays	Maintains	Equal Weight → Equal Weight	—	$18.43	$18.35	-0.4%	+2.9%	+6.2%	+5.3%	+7.9%	+2.7%
Oct 8	Evercore ISI	Maintains	In Line → In Line	—	$18.45	$18.31	-0.8%	+1.2%	+3.8%	+1.0%	+2.6%	-0.1%
Oct 8	Goldman Sachs	Maintains	Neutral → Neutral	—	$18.45	$18.31	-0.8%	+1.2%	+3.8%	+1.0%	+2.6%	-0.1%
Sep 25	Jefferies	Downgrade	Buy → Hold	—	$22.21	$21.47	-3.3%	-12.3%	-10.9%	-10.7%	-10.0%	-11.6%
Aug 20	Deutsche Bank	Maintains	Hold → Hold	—	$22.39	$22.15	-1.1%	+0.1%	-1.1%	-4.4%	-1.6%	+0.4%
Aug 13	BofA Securities	Maintains	Underperform → Underperform	—	$20.04	$20.14	+0.5%	+10.9%	+15.8%	+11.9%	+11.2%	+11.7%
Aug 13	Citigroup	Maintains	Buy → Buy	—	$20.04	$20.14	+0.5%	+10.9%	+15.8%	+11.9%	+11.2%	+11.7%
Aug 13	Evercore ISI	Maintains	In Line → In Line	—	$20.04	$20.14	+0.5%	+10.9%	+15.8%	+11.9%	+11.2%	+11.7%
Aug 13	Baird	Maintains	Outperform → Outperform	—	$20.04	$20.14	+0.5%	+10.9%	+15.8%	+11.9%	+11.2%	+11.7%
Aug 13	Barclays	Maintains	Equal Weight → Equal Weight	—	$20.04	$20.14	+0.5%	+10.9%	+15.8%	+11.9%	+11.2%	+11.7%
Aug 13	TD Cowen	Maintains	Hold → Hold	—	$20.04	$20.14	+0.5%	+10.9%	+15.8%	+11.9%	+11.2%	+11.7%
Aug 8	Evercore ISI	Downgrade	Outperform → In Line	—	$24.57	$24.24	-1.3%	+0.2%	+2.4%	-18.4%	-9.6%	-5.6%
Jul 18	BofA Securities	Maintains	Underperform → Underperform	—	$26.97	$26.70	-1.0%	-4.2%	-3.5%	-0.6%	-4.3%	-5.3%

Recent Filings

8-K · 2.02 !! High

Fortrea Holdings Inc. -- 8-K 2.02: Earnings Results

Fortrea Holdings released quarterly earnings results, with financial details available in the accompanying press release for investor review and analysis.

May 5

8-K

Fortrea Holdings Inc. -- 8-K Filing

Fortrea Holdings (FTRE) reversed a weak first half of 2025 with strong fourth-quarter results and improved book-to-bills in the second half, signaling operational momentum heading into 2026.

Feb 26

Data updated apr 25, 2026 10:17am · Source: massive.com